Patient's Pretreatment Expectations About Post-Lyme Symptoms
NCT03462329 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2026-04-29
Summary
The investigators will focus on pretreatment expectations of patients with early Lyme disease manifested as erythema migrans with the aim of assessing the association between pretreatment expectations quantified with a questionnaire and treatment outcome quantified with the presence of post-Lyme symptoms. Furthermore, the investigators will compare the prevalence of nonspecific symptoms among patients and among age-matched controls without a history of Lyme borreliosis.
Conditions
- Erythema Migrans
Interventions
- DRUG
-
Antibiotics (preferentially oral doxycycline 100 mg bid)
Patients will be treated with antibiotics for Lyme disease.
Sponsors & Collaborators
-
University Medical Centre Ljubljana
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-01
- Primary Completion
- 2028-12-01
- Completion
- 2028-12-01
Countries
- Slovenia
Study Locations
More Related Trials
-
Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis
NCT00942006 ·Status: UNKNOWN ·Phase: NA
-
Clinical Manifestations and Long-Term Outcome in Early Lyme Neuroborreliosis
NCT04653558 ·Status: COMPLETED
-
Study on Early Lyme Neuroborreliosis
NCT00910533 ·Status: UNKNOWN ·Phase: NA
-
Tick-borne Encephalitis and Positive Borrelial Antibodies
NCT02463942 ·Status: UNKNOWN ·Phase: NA
-
Antibiotic Treatment of Multiple Erythema Migrans
NCT01163994 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome
NCT01518192 ·Status: COMPLETED ·Phase: PHASE4
-
Duration of Doxycycline Treatment in MEM Patients
NCT03337932 ·Status: RECRUITING ·Phase: NA
-
Laboratory Characteristics in Chronic Atrophic Acrodermatitis
NCT02147262 ·Status: UNKNOWN ·Phase: NA
-
Aseptic Meningoencephalitis in Slovenia
NCT02328469 ·Status: UNKNOWN
-
Tick-borne Encephalitis and Borrelial Antibodies in Serum
NCT03956446 ·Status: RECRUITING ·Phase: NA
-
Cytokines and Chemokines in Erythema Migrans
NCT02147249 ·Status: UNKNOWN ·Phase: NA
-
Duration of Antibiotic Treatment of Erythema Migrans
NCT00910715 ·Status: COMPLETED ·Phase: NA
-
Clinicaly Manifested Reinfections with Borrelia Burgdorferi Sensu Lato
NCT06835075 ·Status: ACTIVE_NOT_RECRUITING
-
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
NCT00001539 ·Status: RECRUITING
-
Comparison of Doxycycline and Cefuroxime Axetil in Erythema Migrans
NCT03584919 ·Status: COMPLETED ·Phase: NA
-
Persistent Lyme Empiric Antibiotic Study Europe
NCT01207739 ·Status: COMPLETED ·Phase: PHASE4
-
Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis
NCT02553473 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-phospolipid Antibodies in Lyme Borreliosis
NCT06929546 ·Status: NOT_YET_RECRUITING
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease
NCT00000938 ·Status: COMPLETED ·Phase: PHASE3
-
Study and Treatment of Post Lyme Disease (STOP-LD)
NCT00000937 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))
NCT06451913 ·Status: RECRUITING ·Phase: PHASE4
-
Comparison of IFA and LIAISON® for Diagnosis of Early Disseminated Lyme Borreliosis in Children, Younger Than 18 Years
NCT03798704 ·Status: COMPLETED
-
Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
NCT00138801 ·Status: COMPLETED ·Phase: PHASE3
-
Direct Diagnosis of Disseminated Lyme Borreliosis.
NCT04719962 ·Status: UNKNOWN ·Phase: NA
-
Management of Tick-borne Encephalitis
NCT06593249 ·Status: COMPLETED